ВУЗ: Не указан
Категория: Не указан
Дисциплина: Не указана
Добавлен: 03.12.2023
Просмотров: 145
Скачиваний: 1
ВНИМАНИЕ! Если данный файл нарушает Ваши авторские права, то обязательно сообщите нам.
Performing the embryo transfer: a guideline. Fertil Steril [Internet]. 2017;107(4):882–96.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28366416 58.
Brown J, Buckingham K, Buckett W, Abou-Setta AM. Ultrasound versus “clinical touch” for catheter guidance during embryo transfer in women. Cochrane database Syst Rev.
2016;3:CD006107.
59.
Buckett WM. A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer. Fertil Steril [Internet]. 2006;85(3):728–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16500345 60.
Sroga JM, Montville CP, Aubuchon M, Williams DB, Thomas MA. Effect of delayed versus immediate embryo transfer catheter removal on pregnancy outcomes during fresh cycles.
Fertil
Steril
[Internet].
2010;93(6):2088–90.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20116786 61.
Tiras B, Polat M, Korucuoglu U, Zeyneloglu HB, Yarali H. Impact of embryo replacement depth on in vitro fertilization and embryo transfer outcomes. Fertil Steril [Internet].
2010;94(4):1341–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20044085 62.
Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies.
Cochrane database
Syst
Rev.
2014;(2):CD007421.
63.
Craciunas L, Tsampras N, Fitzgerald C. Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet].
2014;101(5):1302–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24602754 64.
Oraif A, Hollet-Caines J, Feyles V, Rebel M, Abduljabar H. Do multiple attempts at embryo transfer affect clinical pregnancy rates? J Obstet Gynaecol Can. 2014;36(5):406–7.
65.
Kroon B, Hart RJ, Wong BMS, Ford E, Yazdani A. Antibiotics prior to embryo transfer in
ART. Cochrane database Syst Rev [Internet]. 2012;(3):CD008995. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22419341 66. van der Ven H, Diedrich K, Al-Hasani S, Pless V, Krebs D. The effect of general anaesthesia on the success of embryo transfer following human in-vitro fertilization. Hum Reprod
[Internet].
1988;3
Suppl
2:81–3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/3068244 67.
European IVF-monitoring Consortium (EIM), European Society of Human Reproduction and
Embryology (ESHRE), Calhaz-Jorge C, De Geyter C, Kupka MS, de Mouzon J, et al.
Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017;32(10):1957–73.
68.
Practice Committee of the American Society for Reproductive Medicine. Electronic address:
ASRM@asrm.org, Practice Committee of the Society for Assisted Reproductive Technology.
Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertil
Steril
[Internet].
2017;107(4):901–3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28292618 69.
Mancuso AC, Boulet SL, Duran E, Munch E, Kissin DM, Van Voorhis BJ. Elective single
149 embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics. Fertil Steril. 2016 Oct;106(5):1107–14.
70.
Kissin DM, Kulkarni AD, Mneimneh A, Warner L, Boulet SL, Crawford S, et al. Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention. Fertil Steril [Internet]. 2015;103(4):954–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25637480 71.
Richter KS, Ginsburg DK, Shipley SK, Lim J, Tucker MJ, Graham JR, et al. Factors associated with birth outcomes from cryopreserved blastocysts: experience from 4,597 autologous transfers of 7,597 cryopreserved blastocysts. Fertil Steril [Internet].
2016;106(2):354--362.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27172399 72.
Chen X, Liu P, Sheng Y, Li W, Tang R, Ding L, et al. The impact of unicornuate uterus on perinatal outcomes after IVF/ICSI cycles: a matched retrospective cohort study. J Matern
Fetal
Neonatal
Med
[Internet].
2018;1–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29649918 73.
JOINT SOGC-CFAS. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet. 2008;102(2):203–16.
74.
Prevention of twin pregnancies after IVF/ICSI by single embryo transfer. ESHRE Campus
Course
Report.
Hum
Reprod
[Internet].
2001;16(4):790–800.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11278236 75.
Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril [Internet]. 1994;61(6):1068–76.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8194619 76.
Connell MT, Szatkowski JM, Terry N, DeCherney AH, Propst AM, Hill MJ. Timing luteal support in assisted reproductive technology: a systematic review. Fertil Steril [Internet].
2015;103(4):939--946.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25638420 77. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane database Syst Rev. 2015;(7):CD009154.
78.
Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod
Biomed
Online
[Internet].
2018;36(6):630–45.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29550390 79.
Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod [Internet]. 2014;29(8):1706–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24847018 80.
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod [Internet].
2017;32(10):2152. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28938733 81.
Применение эстрогенов в программах ВРТ. Научно-практические рекомендации.
РАРЧ. 2015.
82.
Корсак ВС, Каменецкий БА, Михайлов АВ. Значимость толщины и ультразвуковой структуры эндометрия в программе ЭКО. Проблемы репродукции. 2001;7(3):36–9.
83.
Aydin T, Kara M, Nurettin T. Relationship between Endometrial Thickness and In Vitro
Fertilization-Intracytoplasmic Sperm Injection Outcome. Int J Fertil Steril [Internet].
2013;7(1):29–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24520460 84.
Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between
150 endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome.
Reprod
Biol
Endocrinol
[Internet].
2008;6:37.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18764940 85.
Xiao Z, Zhou X, Xu W, Yang J, Xie Q. Natural cycle is superior to hormone replacement therapy cycle for vitrificated-preserved frozen-thawed embryo transfer. Syst Biol Reprod
Med
[Internet].
2012;58(2):107–12.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22206474 86.
Groenewoud ER, Macklon NS, Cohlen BJ, trial study group A. Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial). BMC
Womens
Health
[Internet].
2012;12:27.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22950651 87.
Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol
[Internet].
2014;7(10):6992–7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25400786 88.
Mao G-H, Feng Z, He Y, Huang Y-R. Comparisons of the effects of long-acting and short- acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci [Internet]. 2014;10(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24701229 89.
Jung H, Roh HK. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET. J Assist Reprod Genet
[Internet].
2000;17(1):28–33.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754780 90.
Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril [Internet]. 2004;81(1):1–5.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711532 91.
Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за
2015г. Проблемы репродукции. 2017;23(5):8–22.
92.
Корнеева ЕИ. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. Москва; 2013.
93.
Casper RF. Reducing the Risk of OHSS by GnRH Agonist Triggering. J Clin Endocrinol
Metab
[Internet].
2015;100(12):4396–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26513003 94.
Leitao VMS, Moroni RM, Seko LMD, Nastri CO, Martins WP. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014;101(3):664–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24360566 95.
Sousa M, Cunha M, Teixeira da Silva J, Oliveira C, Silva J, Viana P, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.
Reprod
Biol
Endocrinol
[Internet].
2015;13:66.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26100393 96.
Das M, Son W-Y, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with
GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online [Internet]. 2014;29(5):545–
51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25262236 97.
Refaat B, Dalton E, Ledger WL. Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Reprod Biol Endocrinol
151
[Internet]. 2015;13:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25884617 98.
Shaw JL V, Dey SK, Critchley HOD, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update [Internet]. 16(4):432–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20071358 99.
Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis.
Fertil
Steril
[Internet].
1996;65(6):1093–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8641479 100. Audebert A, Pouly JL, Bonifacie B, Yazbeck C. Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertil Steril [Internet].
2014;102(4):1203–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150389 101. Hjordt Hansen M V, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard O. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand [Internet].
2014;93(5):483–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617701 102. Egbase PE, Al-Sharhan M, Grudzinskas JG. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Hum
Reprod
[Internet].
2000;15(9):1943–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10966991 103. Nazari A, Askari HA, Check JH, O’Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril [Internet]. 1993;60(5):919–21.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8224280 104. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane database Syst Rev. 2013;(7):CD003416.
105. Vloeberghs V, Peeraer K, Pexsters A, D’Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol [Internet]. 2009;23(5):691–709.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19632900 106. Özaltın S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol [Internet]. 2018;89(1):1–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29411339 107. Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online
[Internet].
2008;17(2):237–43.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18681998 108. Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and post- operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod [Internet]. 2006;21(12):3235–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877373 109. Sarhan A, Muasher SJ. Surgical complications of in vitro fertilization. Review. Middle East
Fert Soc J. 2007;12(1):N1.
110. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril [Internet]. 1998;70(4):638–42.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9797090 111. Roest J, Mous H V, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update [Internet].
2(4):345–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9080231 112. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J
152
Obstet
Gynecol
Reprod
Biol
[Internet].
1998;77(2):239–43.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9578285 113. Кулаков ВИ, Леонов БВ. Экстракорпоральное оплодотворение и его новые направления в лечении женского и мужского бесплодия (теоретические и практические подходы): Руководство для врачей. МИА. Москва; 2004. 782 p.
114. Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril [Internet].
1990;53(1):76–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2295348 115. Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet [Internet]. 2017;34(5):627–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299550 116. Kemmann E, Ghazi DM, Corsan GH. Adnexal torsion in menotropin-induced pregnancies.
Obstet
Gynecol
[Internet].
1990;76(3
Pt
1):403–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2116611 117. Bouguizane S, Bibi H, Farhat Y, Dhifallah S, Darraji F, Hidar S, et al. [Adnexal torsion: a report of 135 cases]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(6):535–40.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/14593299 118. Chang HC, Bhatt S, Dogra VS. Pearls and pitfalls in diagnosis of ovarian torsion.
Radiographics
[Internet].
28(5):1355–68.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18794312 119. Huchon C, Fauconnier A. Adnexal torsion: a literature review. Eur J Obstet Gynecol Reprod
Biol
[Internet].
2010;150(1):8–12.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20189289 120. Mashiach R, Melamed N, Gilad N, Ben-Shitrit G, Meizner I. Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med [Internet].
2011;30(9):1205–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21876091 121. Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Hum
Reprod
Update
[Internet].
6(5):432–41.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11045874 122. Assisted reproductive technology in Europe 2013: results generated from European registers by ESHRE., Calhaz-Jorge C, Christian De Geyter, M S Kupka et al. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod [Internet]. 2017;32(10):1957–73.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26908842 123. Pereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic Prophylaxis for
Gynecologic Procedures prior to and during the Utilization of Assisted Reproductive
Technologies: A Systematic Review. J Pathog [Internet]. 2016;2016:4698314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27047692 124. Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med [Internet]. 2008;5(1):194–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17433085 125. Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am [Internet]. 2008;35(2):211--20, viii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18423241 126. Brackett NL, Ibrahim E, Iremashvili V, Aballa TC, Lynne CM. Treatment for ejaculatory dysfunction in men with spinal cord injury: an 18-year single center experience. J Urol
[Internet].
2010;183(6):2304–8.
Available from:
153 http://www.ncbi.nlm.nih.gov/pubmed/20400139 127. Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation: an electrifying approach.
Semin
Reprod
Med
[Internet].
2009;27(2):179–85.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19247920 128. Brackett NL, Lynne CM, Ibrahim E, Ohl DA, Sønksen J. Treatment of infertility in men with spinal cord injury. Nat Rev Urol [Internet]. 2010;7(3):162–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20157304 129. Корнеев ИА, Зассеев РД. Преодоление бесплодия у мужчин с ретроградной эякуляцией и анэякуляцией. Урологические ведомости. 2017;7(2):10–5.
130. Colpi GM, Piediferro G, Nerva F, Giacchetta D, Colpi EM, Piatti E. Sperm retrieval for intra-cytoplasmic sperm injection in non-obstructive azoospermia. Minerva Urol Nefrol
[Internet].
2005;57(2):99–107.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15951734 131. Deruyver Y, Vanderschueren D, Van der Aa F. Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology
[Internet]. 2014;2(1):20–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24193894 132. Krausz C, Degl’Innocenti S. Y chromosome and male infertility: update, 2006. Front Biosci
[Internet].
2006;11:3049–61.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/16720375 133. Ghanem M, Bakr NI, Elgayaar MA, El Mongy S, Fathy H, Ibrahim A-HA. Comparison of the outcome of intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia in the first cycle: a report of case series and meta-analysis. Int J Androl
[Internet].
2005;28(1):16–21.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15679616 134. Vernaeve V, Tournaye H, Osmanagaoglu K, Verheyen G, Van Steirteghem A, Devroey P.
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril
[Internet].
2003;79(3):529–33.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12620435 135. Vloeberghs V, Verheyen G, Haentjens P, Goossens A, Polyzos NP, Tournaye H. How successful is TESE-ICSI in couples with non-obstructive azoospermia? Hum Reprod
[Internet].
2015;30(8):1790–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26082482 136. Aksglaede L, Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review.
Eur
J
Endocrinol
[Internet].
2013;168(4):R67--76.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23504510 137. Gies I, De Schepper J, Goossens E, Van Saen D, Pennings G, Tournaye H. Spermatogonial stem cell preservation in boys with Klinefelter syndrome: to bank or not to bank, that’s the question.
Fertil
Steril
[Internet].
2012;98(2):284–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22608314 138. Kastrop PM, Weima SM, Van Kooij RJ, Te Velde ER. Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt. Hum Reprod
[Internet].
1999;14(1):65–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10374096 139. Verheyen G, Tournaye H, Staessen C, De Vos A, Vandervorst M, Van Steirteghem A.
Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm
154 injection in patients with asthenozoospermia. Hum Reprod [Internet]. 1999;14(9):2313–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10469701 140. Payne D, Flaherty SP, Jeffrey R, Warnes GM, Matthews CD. Successful treatment of severe male factor infertility in 100 consecutive cycles using intracytoplasmic sperm injection. Hum
Reprod
[Internet].
1994;9(11):2051–7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/7868673 141. Plachot M, Belaisch-Allart J, Mayenga J-M, Chouraqui A, Tesquier L, Serkine AM.
Outcome of conventional IVF and ICSI on sibling oocytes in mild male factor infertility.
Hum
Reprod
[Internet].
2002;17(2):362–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11821279 142. Henkel RR, Schill W-B. Sperm preparation for ART. Reprod Biol Endocrinol [Internet].
2003;1:108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14617368 143. Beydola T, Sharma RK, Agarwal A. Sperm preparation and selection techniques. Med Surg
Manag male Infertil. 2014;(29):244–51.
144. on Good EGG. Revised guidelines for good practice in IVF laboratories (2015): Guideline of the European Society of Human Reproduction and Embryology.
145. Huang Z, Li J, Wang L, Yan J, Shi Y, Li S. Brief co-incubation of sperm and oocytes for in vitro fertilization techniques. Cochrane database Syst Rev. 2013;(4):CD009391.
146. Kazem R, Thompson LA, Srikantharajah A, Laing MA, Hamilton MP, Templeton A.
Cryopreservation of human oocytes and fertilization by two techniques: in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod [Internet]. 1995;10(10):2650–4.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8567786 147. Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update [Internet].
13(6):591–605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17846105 148. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, et al. ESHRE PGD
Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod
[Internet].
2011;26(1):41–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20966459 149. Thornhill AR, DeDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, et al.
ESHRE PGD Consortium “Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)”. Hum Reprod [Internet].
2005;20(1):35–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15539444 150. ESHRE Capri Workshop Group. Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. Hum Reprod Update [Internet]. 13(6):515–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17630396 151. Practice Committees of the American Society for Reproductive Medicine and Society for
Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril [Internet]. 2012;98(6):1395–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22981171 152. van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N. Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertil Steril [Internet]. 2005;83(3):612–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15749489 153. Kinzer DR, Barrett CB, Powers RD. Prognosis for clinical pregnancy and delivery after total fertilization failure during conventional in vitro fertilization or intracytoplasmic sperm injection.
Fertil
Steril
[Internet].
2008;90(2):284–8.
Available from:
155 http://www.ncbi.nlm.nih.gov/pubmed/17714711 154. Johnson LNC, Sasson IE, Sammel MD, Dokras A. Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil Steril
[Internet].
2013;100(3):704–11.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23773312 155. Moreno C, Ruiz A, Simón C, Pellicer A, Remohí J. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod [Internet]. 1998;13(8):2126–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9756282 156. Luna M, Bigelow C, Duke M, Ruman J, Sandler B, Grunfeld L, et al. Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved? J Assist Reprod
Genet
[Internet].
2011;28(10):911–5.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21792665 157. Kim HH, Bundorf MK, Behr B, McCallum SW. Use and outcomes of intracytoplasmic sperm injection for non-male factor infertility. Fertil Steril [Internet]. 2007;88(3):622–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17445809 158. Hwang JL, Lin YH, Tsai YL. In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques. J Assist Reprod Genet [Internet].
2000;17(1):39–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754782 159. Nagy ZP, Cecile J, Liu J, Loccufier A, Devroey P, Van Steirteghem A. Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report.
Fertil
Steril
[Internet].
1996;65(5):1047–50.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8612833 160. Tucker M, Graham J, Han T, Stillman R, Levy M. Conventional insemination versus intracytoplasmic sperm injection.
Lancet
(London,
England)
[Internet].
2001;358(9293):1645–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11716920 161. Teixeira DM, Barbosa MAP, Ferriani RA, Navarro PA, Raine-Fenning N, Nastri CO, et al.
Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction. Cochrane database Syst Rev. 2013;(7):CD010167.
162. McDowell S, Kroon B, Ford E, Hook Y, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane database Syst
Rev.
2014;(10):CD010461.
163. Cohen J, Alikani M, Trowbridge J, Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis. Hum Reprod
[Internet].
1992;7(5):685–91.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/1639990 164. Zeng M, Su S, Li L. The effect of laser-assisted hatching on pregnancy outcomes of cryopreserved-thawed embryo transfer: a meta-analysis of randomized controlled trials.
Lasers
Med
Sci
[Internet].
2018;33(3):655–66.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29116610 165. Carney S-K, Das S, Blake D, Farquhar C, Seif MMW, Nelson L. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI).
Cochrane database Syst Rev. 2012;12:CD001894.
166. Capalbo A, Romanelli V, Cimadomo D, Girardi L, Stoppa M, Dovere L, et al. Implementing
PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management. J Assist Reprod Genet [Internet]. 2016;33(10):1279–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27423665
156 167. Martins WP, Rocha IA, Ferriani RA, Nastri CO. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update
[Internet]. 17(4):438–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21474527 168. Li D, Yang D-L, An J, Jiao J, Zhou Y-M, Wu Q-J, et al. Effect of assisted hatching on pregnancy outcomes: a systematic review and meta-analysis of randomized controlled trials.
Sci
Rep
[Internet].
2016;6:31228.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/27503701 169. Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, Verpoest W, et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod [Internet]. 2008;23(3):481–
92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18156649 170. De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, et al. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod [Internet]. 2009;24(12):2988–96.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19773223 171. Dumoulin JC, Bras M, Coonen E, Dreesen J, Geraedts JP, Evers JL. Effect of Ca2+/Mg2+- free medium on the biopsy procedure for preimplantation genetic diagnosis and further development of human embryos. Hum Reprod [Internet]. 1998;13(1O):2880–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9804249 172. Kahraman S, Bahçe M, Samli H, Imirzalioğlu N, Yakisn K, Cengiz G, et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod [Internet].
2000;15(9):2003–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10967004 173. Munné S, Cohen J. Unsuitability of multinucleated human blastomeres for preimplantation genetic diagnosis.
Hum Reprod [Internet]. 1993;8(7):1120–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8408497 174. Geber S, Bossi R, Lisboa CB, Valle M, Sampaio M. Laser confers less embryo exposure than acid tyrode for embryo biopsy in preimplantation genetic diagnosis cycles: a randomized study.
Reprod
Biol
Endocrinol
[Internet].
2011;9:58.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21527004 175. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obs
Gynecol. 1999;13(3):307–11.
176. Wininger JD, Taylor TH, Orris JJ, Glassner M, Anderson SH. Pregnancy after rebiopsy and vitrification of blastocysts following allele dropout after day 3 biopsy. Fertil Steril [Internet].
2011;95(3):1122.e1--2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20951376 177. Greco E, Biricik A, Cotarelo RP, Iammarone E, Rubino P, Tesarik J, et al. Successful implantation and live birth of a healthy boy after triple biopsy and double vitrification of oocyte-embryo-blastocyst.
Springerplus
[Internet].
2015;4:22.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25625041 178. Eldar-Geva T, Srebnik N, Altarescu G, Varshaver I, Brooks B, Levy-Lahad E, et al. Neonatal outcome after preimplantation genetic diagnosis. Fertil Steril [Internet]. 2014;102(4):1016–
21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25064409 179. De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis.
Prenat
Diagn
[Internet].
2001;21(9):767–80.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11559914 180. Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28366416 58.
Brown J, Buckingham K, Buckett W, Abou-Setta AM. Ultrasound versus “clinical touch” for catheter guidance during embryo transfer in women. Cochrane database Syst Rev.
2016;3:CD006107.
59.
Buckett WM. A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer. Fertil Steril [Internet]. 2006;85(3):728–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16500345 60.
Sroga JM, Montville CP, Aubuchon M, Williams DB, Thomas MA. Effect of delayed versus immediate embryo transfer catheter removal on pregnancy outcomes during fresh cycles.
Fertil
Steril
[Internet].
2010;93(6):2088–90.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20116786 61.
Tiras B, Polat M, Korucuoglu U, Zeyneloglu HB, Yarali H. Impact of embryo replacement depth on in vitro fertilization and embryo transfer outcomes. Fertil Steril [Internet].
2010;94(4):1341–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20044085 62.
Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies.
Cochrane database
Syst
Rev.
2014;(2):CD007421.
63.
Craciunas L, Tsampras N, Fitzgerald C. Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet].
2014;101(5):1302–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24602754 64.
Oraif A, Hollet-Caines J, Feyles V, Rebel M, Abduljabar H. Do multiple attempts at embryo transfer affect clinical pregnancy rates? J Obstet Gynaecol Can. 2014;36(5):406–7.
65.
Kroon B, Hart RJ, Wong BMS, Ford E, Yazdani A. Antibiotics prior to embryo transfer in
ART. Cochrane database Syst Rev [Internet]. 2012;(3):CD008995. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22419341 66. van der Ven H, Diedrich K, Al-Hasani S, Pless V, Krebs D. The effect of general anaesthesia on the success of embryo transfer following human in-vitro fertilization. Hum Reprod
[Internet].
1988;3
Suppl
2:81–3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/3068244 67.
European IVF-monitoring Consortium (EIM), European Society of Human Reproduction and
Embryology (ESHRE), Calhaz-Jorge C, De Geyter C, Kupka MS, de Mouzon J, et al.
Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017;32(10):1957–73.
68.
Practice Committee of the American Society for Reproductive Medicine. Electronic address:
ASRM@asrm.org, Practice Committee of the Society for Assisted Reproductive Technology.
Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertil
Steril
[Internet].
2017;107(4):901–3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28292618 69.
Mancuso AC, Boulet SL, Duran E, Munch E, Kissin DM, Van Voorhis BJ. Elective single
149 embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics. Fertil Steril. 2016 Oct;106(5):1107–14.
70.
Kissin DM, Kulkarni AD, Mneimneh A, Warner L, Boulet SL, Crawford S, et al. Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention. Fertil Steril [Internet]. 2015;103(4):954–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25637480 71.
Richter KS, Ginsburg DK, Shipley SK, Lim J, Tucker MJ, Graham JR, et al. Factors associated with birth outcomes from cryopreserved blastocysts: experience from 4,597 autologous transfers of 7,597 cryopreserved blastocysts. Fertil Steril [Internet].
2016;106(2):354--362.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27172399 72.
Chen X, Liu P, Sheng Y, Li W, Tang R, Ding L, et al. The impact of unicornuate uterus on perinatal outcomes after IVF/ICSI cycles: a matched retrospective cohort study. J Matern
Fetal
Neonatal
Med
[Internet].
2018;1–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29649918 73.
JOINT SOGC-CFAS. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet. 2008;102(2):203–16.
74.
Prevention of twin pregnancies after IVF/ICSI by single embryo transfer. ESHRE Campus
Course
Report.
Hum
Reprod
[Internet].
2001;16(4):790–800.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11278236 75.
Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril [Internet]. 1994;61(6):1068–76.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8194619 76.
Connell MT, Szatkowski JM, Terry N, DeCherney AH, Propst AM, Hill MJ. Timing luteal support in assisted reproductive technology: a systematic review. Fertil Steril [Internet].
2015;103(4):939--946.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25638420 77. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane database Syst Rev. 2015;(7):CD009154.
78.
Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod
Biomed
Online
[Internet].
2018;36(6):630–45.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29550390 79.
Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod [Internet]. 2014;29(8):1706–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24847018 80.
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod [Internet].
2017;32(10):2152. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28938733 81.
Применение эстрогенов в программах ВРТ. Научно-практические рекомендации.
РАРЧ. 2015.
82.
Корсак ВС, Каменецкий БА, Михайлов АВ. Значимость толщины и ультразвуковой структуры эндометрия в программе ЭКО. Проблемы репродукции. 2001;7(3):36–9.
83.
Aydin T, Kara M, Nurettin T. Relationship between Endometrial Thickness and In Vitro
Fertilization-Intracytoplasmic Sperm Injection Outcome. Int J Fertil Steril [Internet].
2013;7(1):29–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24520460 84.
Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between
150 endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome.
Reprod
Biol
Endocrinol
[Internet].
2008;6:37.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18764940 85.
Xiao Z, Zhou X, Xu W, Yang J, Xie Q. Natural cycle is superior to hormone replacement therapy cycle for vitrificated-preserved frozen-thawed embryo transfer. Syst Biol Reprod
Med
[Internet].
2012;58(2):107–12.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22206474 86.
Groenewoud ER, Macklon NS, Cohlen BJ, trial study group A. Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial). BMC
Womens
Health
[Internet].
2012;12:27.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22950651 87.
Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol
[Internet].
2014;7(10):6992–7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25400786 88.
Mao G-H, Feng Z, He Y, Huang Y-R. Comparisons of the effects of long-acting and short- acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci [Internet]. 2014;10(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24701229 89.
Jung H, Roh HK. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET. J Assist Reprod Genet
[Internet].
2000;17(1):28–33.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754780 90.
Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril [Internet]. 2004;81(1):1–5.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711532 91.
Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за
2015г. Проблемы репродукции. 2017;23(5):8–22.
92.
Корнеева ЕИ. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. Москва; 2013.
93.
Casper RF. Reducing the Risk of OHSS by GnRH Agonist Triggering. J Clin Endocrinol
Metab
[Internet].
2015;100(12):4396–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26513003 94.
Leitao VMS, Moroni RM, Seko LMD, Nastri CO, Martins WP. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014;101(3):664–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24360566 95.
Sousa M, Cunha M, Teixeira da Silva J, Oliveira C, Silva J, Viana P, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.
Reprod
Biol
Endocrinol
[Internet].
2015;13:66.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26100393 96.
Das M, Son W-Y, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with
GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online [Internet]. 2014;29(5):545–
51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25262236 97.
Refaat B, Dalton E, Ledger WL. Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Reprod Biol Endocrinol
151
[Internet]. 2015;13:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25884617 98.
Shaw JL V, Dey SK, Critchley HOD, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update [Internet]. 16(4):432–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20071358 99.
Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis.
Fertil
Steril
[Internet].
1996;65(6):1093–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8641479 100. Audebert A, Pouly JL, Bonifacie B, Yazbeck C. Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertil Steril [Internet].
2014;102(4):1203–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150389 101. Hjordt Hansen M V, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard O. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand [Internet].
2014;93(5):483–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617701 102. Egbase PE, Al-Sharhan M, Grudzinskas JG. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Hum
Reprod
[Internet].
2000;15(9):1943–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10966991 103. Nazari A, Askari HA, Check JH, O’Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril [Internet]. 1993;60(5):919–21.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8224280 104. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane database Syst Rev. 2013;(7):CD003416.
105. Vloeberghs V, Peeraer K, Pexsters A, D’Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol [Internet]. 2009;23(5):691–709.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19632900 106. Özaltın S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol [Internet]. 2018;89(1):1–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29411339 107. Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online
[Internet].
2008;17(2):237–43.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18681998 108. Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and post- operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod [Internet]. 2006;21(12):3235–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877373 109. Sarhan A, Muasher SJ. Surgical complications of in vitro fertilization. Review. Middle East
Fert Soc J. 2007;12(1):N1.
110. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril [Internet]. 1998;70(4):638–42.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9797090 111. Roest J, Mous H V, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update [Internet].
2(4):345–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9080231 112. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J
152
Obstet
Gynecol
Reprod
Biol
[Internet].
1998;77(2):239–43.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9578285 113. Кулаков ВИ, Леонов БВ. Экстракорпоральное оплодотворение и его новые направления в лечении женского и мужского бесплодия (теоретические и практические подходы): Руководство для врачей. МИА. Москва; 2004. 782 p.
114. Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril [Internet].
1990;53(1):76–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2295348 115. Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet [Internet]. 2017;34(5):627–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299550 116. Kemmann E, Ghazi DM, Corsan GH. Adnexal torsion in menotropin-induced pregnancies.
Obstet
Gynecol
[Internet].
1990;76(3
Pt
1):403–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2116611 117. Bouguizane S, Bibi H, Farhat Y, Dhifallah S, Darraji F, Hidar S, et al. [Adnexal torsion: a report of 135 cases]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(6):535–40.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/14593299 118. Chang HC, Bhatt S, Dogra VS. Pearls and pitfalls in diagnosis of ovarian torsion.
Radiographics
[Internet].
28(5):1355–68.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18794312 119. Huchon C, Fauconnier A. Adnexal torsion: a literature review. Eur J Obstet Gynecol Reprod
Biol
[Internet].
2010;150(1):8–12.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20189289 120. Mashiach R, Melamed N, Gilad N, Ben-Shitrit G, Meizner I. Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med [Internet].
2011;30(9):1205–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21876091 121. Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Hum
Reprod
Update
[Internet].
6(5):432–41.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11045874 122. Assisted reproductive technology in Europe 2013: results generated from European registers by ESHRE., Calhaz-Jorge C, Christian De Geyter, M S Kupka et al. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod [Internet]. 2017;32(10):1957–73.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26908842 123. Pereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic Prophylaxis for
Gynecologic Procedures prior to and during the Utilization of Assisted Reproductive
Technologies: A Systematic Review. J Pathog [Internet]. 2016;2016:4698314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27047692 124. Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med [Internet]. 2008;5(1):194–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17433085 125. Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am [Internet]. 2008;35(2):211--20, viii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18423241 126. Brackett NL, Ibrahim E, Iremashvili V, Aballa TC, Lynne CM. Treatment for ejaculatory dysfunction in men with spinal cord injury: an 18-year single center experience. J Urol
[Internet].
2010;183(6):2304–8.
Available from:
153 http://www.ncbi.nlm.nih.gov/pubmed/20400139 127. Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation: an electrifying approach.
Semin
Reprod
Med
[Internet].
2009;27(2):179–85.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19247920 128. Brackett NL, Lynne CM, Ibrahim E, Ohl DA, Sønksen J. Treatment of infertility in men with spinal cord injury. Nat Rev Urol [Internet]. 2010;7(3):162–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20157304 129. Корнеев ИА, Зассеев РД. Преодоление бесплодия у мужчин с ретроградной эякуляцией и анэякуляцией. Урологические ведомости. 2017;7(2):10–5.
1 ... 14 15 16 17 18 19 20 21 22
130. Colpi GM, Piediferro G, Nerva F, Giacchetta D, Colpi EM, Piatti E. Sperm retrieval for intra-cytoplasmic sperm injection in non-obstructive azoospermia. Minerva Urol Nefrol
[Internet].
2005;57(2):99–107.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15951734 131. Deruyver Y, Vanderschueren D, Van der Aa F. Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology
[Internet]. 2014;2(1):20–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24193894 132. Krausz C, Degl’Innocenti S. Y chromosome and male infertility: update, 2006. Front Biosci
[Internet].
2006;11:3049–61.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/16720375 133. Ghanem M, Bakr NI, Elgayaar MA, El Mongy S, Fathy H, Ibrahim A-HA. Comparison of the outcome of intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia in the first cycle: a report of case series and meta-analysis. Int J Androl
[Internet].
2005;28(1):16–21.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15679616 134. Vernaeve V, Tournaye H, Osmanagaoglu K, Verheyen G, Van Steirteghem A, Devroey P.
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril
[Internet].
2003;79(3):529–33.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12620435 135. Vloeberghs V, Verheyen G, Haentjens P, Goossens A, Polyzos NP, Tournaye H. How successful is TESE-ICSI in couples with non-obstructive azoospermia? Hum Reprod
[Internet].
2015;30(8):1790–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26082482 136. Aksglaede L, Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review.
Eur
J
Endocrinol
[Internet].
2013;168(4):R67--76.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23504510 137. Gies I, De Schepper J, Goossens E, Van Saen D, Pennings G, Tournaye H. Spermatogonial stem cell preservation in boys with Klinefelter syndrome: to bank or not to bank, that’s the question.
Fertil
Steril
[Internet].
2012;98(2):284–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22608314 138. Kastrop PM, Weima SM, Van Kooij RJ, Te Velde ER. Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt. Hum Reprod
[Internet].
1999;14(1):65–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10374096 139. Verheyen G, Tournaye H, Staessen C, De Vos A, Vandervorst M, Van Steirteghem A.
Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm
154 injection in patients with asthenozoospermia. Hum Reprod [Internet]. 1999;14(9):2313–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10469701 140. Payne D, Flaherty SP, Jeffrey R, Warnes GM, Matthews CD. Successful treatment of severe male factor infertility in 100 consecutive cycles using intracytoplasmic sperm injection. Hum
Reprod
[Internet].
1994;9(11):2051–7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/7868673 141. Plachot M, Belaisch-Allart J, Mayenga J-M, Chouraqui A, Tesquier L, Serkine AM.
Outcome of conventional IVF and ICSI on sibling oocytes in mild male factor infertility.
Hum
Reprod
[Internet].
2002;17(2):362–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11821279 142. Henkel RR, Schill W-B. Sperm preparation for ART. Reprod Biol Endocrinol [Internet].
2003;1:108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14617368 143. Beydola T, Sharma RK, Agarwal A. Sperm preparation and selection techniques. Med Surg
Manag male Infertil. 2014;(29):244–51.
144. on Good EGG. Revised guidelines for good practice in IVF laboratories (2015): Guideline of the European Society of Human Reproduction and Embryology.
145. Huang Z, Li J, Wang L, Yan J, Shi Y, Li S. Brief co-incubation of sperm and oocytes for in vitro fertilization techniques. Cochrane database Syst Rev. 2013;(4):CD009391.
146. Kazem R, Thompson LA, Srikantharajah A, Laing MA, Hamilton MP, Templeton A.
Cryopreservation of human oocytes and fertilization by two techniques: in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod [Internet]. 1995;10(10):2650–4.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8567786 147. Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update [Internet].
13(6):591–605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17846105 148. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, et al. ESHRE PGD
Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod
[Internet].
2011;26(1):41–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20966459 149. Thornhill AR, DeDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, et al.
ESHRE PGD Consortium “Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)”. Hum Reprod [Internet].
2005;20(1):35–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15539444 150. ESHRE Capri Workshop Group. Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. Hum Reprod Update [Internet]. 13(6):515–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17630396 151. Practice Committees of the American Society for Reproductive Medicine and Society for
Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril [Internet]. 2012;98(6):1395–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22981171 152. van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N. Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertil Steril [Internet]. 2005;83(3):612–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15749489 153. Kinzer DR, Barrett CB, Powers RD. Prognosis for clinical pregnancy and delivery after total fertilization failure during conventional in vitro fertilization or intracytoplasmic sperm injection.
Fertil
Steril
[Internet].
2008;90(2):284–8.
Available from:
155 http://www.ncbi.nlm.nih.gov/pubmed/17714711 154. Johnson LNC, Sasson IE, Sammel MD, Dokras A. Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil Steril
[Internet].
2013;100(3):704–11.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23773312 155. Moreno C, Ruiz A, Simón C, Pellicer A, Remohí J. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod [Internet]. 1998;13(8):2126–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9756282 156. Luna M, Bigelow C, Duke M, Ruman J, Sandler B, Grunfeld L, et al. Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved? J Assist Reprod
Genet
[Internet].
2011;28(10):911–5.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21792665 157. Kim HH, Bundorf MK, Behr B, McCallum SW. Use and outcomes of intracytoplasmic sperm injection for non-male factor infertility. Fertil Steril [Internet]. 2007;88(3):622–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17445809 158. Hwang JL, Lin YH, Tsai YL. In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques. J Assist Reprod Genet [Internet].
2000;17(1):39–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754782 159. Nagy ZP, Cecile J, Liu J, Loccufier A, Devroey P, Van Steirteghem A. Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report.
Fertil
Steril
[Internet].
1996;65(5):1047–50.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8612833 160. Tucker M, Graham J, Han T, Stillman R, Levy M. Conventional insemination versus intracytoplasmic sperm injection.
Lancet
(London,
England)
[Internet].
2001;358(9293):1645–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11716920 161. Teixeira DM, Barbosa MAP, Ferriani RA, Navarro PA, Raine-Fenning N, Nastri CO, et al.
Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction. Cochrane database Syst Rev. 2013;(7):CD010167.
162. McDowell S, Kroon B, Ford E, Hook Y, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane database Syst
Rev.
2014;(10):CD010461.
163. Cohen J, Alikani M, Trowbridge J, Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis. Hum Reprod
[Internet].
1992;7(5):685–91.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/1639990 164. Zeng M, Su S, Li L. The effect of laser-assisted hatching on pregnancy outcomes of cryopreserved-thawed embryo transfer: a meta-analysis of randomized controlled trials.
Lasers
Med
Sci
[Internet].
2018;33(3):655–66.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29116610 165. Carney S-K, Das S, Blake D, Farquhar C, Seif MMW, Nelson L. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI).
Cochrane database Syst Rev. 2012;12:CD001894.
166. Capalbo A, Romanelli V, Cimadomo D, Girardi L, Stoppa M, Dovere L, et al. Implementing
PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management. J Assist Reprod Genet [Internet]. 2016;33(10):1279–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27423665
156 167. Martins WP, Rocha IA, Ferriani RA, Nastri CO. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update
[Internet]. 17(4):438–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21474527 168. Li D, Yang D-L, An J, Jiao J, Zhou Y-M, Wu Q-J, et al. Effect of assisted hatching on pregnancy outcomes: a systematic review and meta-analysis of randomized controlled trials.
Sci
Rep
[Internet].
2016;6:31228.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/27503701 169. Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, Verpoest W, et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod [Internet]. 2008;23(3):481–
92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18156649 170. De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, et al. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod [Internet]. 2009;24(12):2988–96.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19773223 171. Dumoulin JC, Bras M, Coonen E, Dreesen J, Geraedts JP, Evers JL. Effect of Ca2+/Mg2+- free medium on the biopsy procedure for preimplantation genetic diagnosis and further development of human embryos. Hum Reprod [Internet]. 1998;13(1O):2880–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9804249 172. Kahraman S, Bahçe M, Samli H, Imirzalioğlu N, Yakisn K, Cengiz G, et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod [Internet].
2000;15(9):2003–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10967004 173. Munné S, Cohen J. Unsuitability of multinucleated human blastomeres for preimplantation genetic diagnosis.
Hum Reprod [Internet]. 1993;8(7):1120–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8408497 174. Geber S, Bossi R, Lisboa CB, Valle M, Sampaio M. Laser confers less embryo exposure than acid tyrode for embryo biopsy in preimplantation genetic diagnosis cycles: a randomized study.
Reprod
Biol
Endocrinol
[Internet].
2011;9:58.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21527004 175. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obs
Gynecol. 1999;13(3):307–11.
176. Wininger JD, Taylor TH, Orris JJ, Glassner M, Anderson SH. Pregnancy after rebiopsy and vitrification of blastocysts following allele dropout after day 3 biopsy. Fertil Steril [Internet].
2011;95(3):1122.e1--2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20951376 177. Greco E, Biricik A, Cotarelo RP, Iammarone E, Rubino P, Tesarik J, et al. Successful implantation and live birth of a healthy boy after triple biopsy and double vitrification of oocyte-embryo-blastocyst.
Springerplus
[Internet].
2015;4:22.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25625041 178. Eldar-Geva T, Srebnik N, Altarescu G, Varshaver I, Brooks B, Levy-Lahad E, et al. Neonatal outcome after preimplantation genetic diagnosis. Fertil Steril [Internet]. 2014;102(4):1016–
21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25064409 179. De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis.
Prenat
Diagn
[Internet].
2001;21(9):767–80.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11559914 180. Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis